New NNT→Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates https://t.co/V01VonT56b
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @neo_papers: Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates #neoTwitter https://t.co/ykQ6Jwhnan
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @neo_papers: Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates #neoTwitter https://t.co/ykQ6Jwhnan
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates #neoTwitter https://t.co/ykQ6Jwhnan
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
RT @CochraneNeonate: Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adver…
Adjunct pentoxifylline therapy in neonatal sepsis may decrease mortality and length of hospital stay without any adverse effects. Read the full review (third update) for the other comparisons: https://t.co/3G2DV7Esah #NEC @AmerAcadPeds @ESPR_ESN https://